Market Size (2016)
2016
$661.38M
Healthcare
Metagenomic Sequencing Market
By Segment, By Region, And Segment Forecasts, 2016 – 2027
Vertical: HealthcareBase Year: 201911 Sections
Executive Summary
Metagenomic Sequencing Market — Snapshot
Projected (2027)
2027
$3.39B
CAGR (2016–2027)
16.0%
16.0%Key Players
109+
Metagenomic sequencing is a modern genomics technique that helps in the analysis of microbial DNA from various environmental communities. Metagenomics sequencing allows researchers to analyze genes in any given sample. This method enables access to bacterial diversity and identifies the presence of microbes in various environments.
Factors that drive the market growth are the wide range of applications of metagenomics in various fields, rising government funding and initiatives for growth of sequencing techniques, and declining cost of sequencing. However, unfavorable regulatory policies are hampering the growth of the market.
Key Insight
The Metagenomic Sequencing Market market is projected to grow at a CAGR of 16.0% from 2016 to 2027.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: Europe, Asia Pacific, Middle East and Africa, Americas.
- Market Segmentation: The market is analyzed across 4 segments: Reagents & Consumables, Services, Instruments, Analysis and Data Interpretation Solutions. Forecasts are provided for each segment from 2016 to 2027.
- Competitive Landscape: 109 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Metagenomic Sequencing Market — Growth Trajectory
Scope of the Study
The scope of the global metagenomic sequencing market study includes market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on product & service, application, technology, and region.
Research Objective
To provide a comprehensive analysis of the global metagenomic sequencing market and its sub-segments, thereby providing a detailed structure of the industry To provide detailed insights into factors driving and restraining the growth of the global metagenomic sequencing marketTo estimate the market size of the global metagenomic sequencing market where 2017 to 2018 would be the historic period, 2019 shall be the base year, and 2020 to 2027 will be the forecast period for the studyTo provide region-wise market value analysis for various segments of the global metagenomic sequencing marketTo provide strategic profiling of key companies (manufacturers and distributors) present across the globe and comprehensively analyze their competitiveness/competitive landscape in this marketTo provide a distribution chain analysis/value chain for the global metagenomic sequencing market
Metagenomic Sequencing Market — Growth Trajectory
Reagents & Consumables
Services
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Products & Services is broken down into: Reagents & Consumables, Services, Analysis and Data Interpretation Solutions, Instruments.
- Technology is broken down into: 16S rRNA-Based Sequencing, Shotgun Metagenomics Sequencing, Metatranscriptomics, De Novo Assembly.
- Application is broken down into: Biotechnology, Infectious Disease Diagnosis, Biofuel, Agriculture, Gut Microbe Characterization, Environmental Remediation, Others.
Geographic Analysis
Regional market breakdown
- Europe Europe market size reached $148.17M in 2016 and is projected to reach $779.82M by 2027, growing at a CAGR of 16.3%.
- Asia Pacific Asia Pacific market size reached $82.84M in 2016 and is projected to reach $429.80M by 2027, growing at a CAGR of 16.1%.
- Middle East and Africa Middle East and Africa market size reached $38.48M in 2016 and is projected to reach $105.95M by 2027, growing at a CAGR of 9.6%.
- Americas Americas market size reached $391.89M in 2016 and is projected to reach $2.08B by 2027, growing at a CAGR of 16.4%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Metagenomic Sequencing Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2019
Historical Period
2016 – 2019
Forecast Period
2019 – 2027
Primary Interviews
150+
Research Process
Historical data (2016–2019) and forecast period (2019–2027)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Metagenomic Sequencing Market — Competitive Analysis
Threat of New Entrants
The threat of new entrants in the global metagenomic sequencing market is medium. Any company trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. The market is also characterized by a high degree of brand loyalty, where establishing a brand name is difficult for newcomers. The rise in the demand for metagenomic sequencing technology owing to its potential growth in the coming future is expected to attract the currently established and other manufacturers to focus more on this segment. Furthermore, the cost involved in research and development (R&D) is comparatively high, which does not comfort the new entrants to enter the market easily.
Bargaining Power of Suppliers
The suppliers in the global metagenomic sequencing market are raw material suppliers. There are various suppliers present in the global metagenomic sequencing market. At present, there are a number of suppliers present in the market owing to the high demand, increasing government support, and the availability of huge opportunities for the development of the market. The market is dominated by a few existing significant companies, and they hold the major share in the global market and have the capability of fluctuating the costs of the products. However, the switching cost of these suppliers is low to medium because suppliers tend to enter into long-term associations, partnerships, and deals with the other product manufacturing companies. Therefore, the overall bargaining power of suppliers in the global advanced wound therapy devices market is medium.
Threat of Substitutes
The threat of substitutes in the global metagenomic sequencing market is medium, as it is still an upcoming technology. Although there are no direct threats, other genome sequencing technologies take up a significant share.
Bargaining Power of Buyers
The bargaining power of buyers is moderate in the global metagenomic sequencing market. The presence of buyers in the market is growing due to the increasing awareness about the different products, along with the rising prevalence of cancer. Additionally, the presence of providers is also increasing, which makes the bargaining power of buyers moderate due to the low switching costs.
Intensity of Rivalry
The degree of competition in the global metagenomic sequencing market is high. Companies involved in the metagenomic sequencing market are trying to introduce more advanced products, for differentiating their product from their rivals. Moreover, manufacturers also focus on the enhanced safety and quality of the products to increase the demand for these products in developed countries and developing regions. To overcome the competition, players are engaged in partnering with established organizations and welcoming tie-ups.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Metagenomic Sequencing Market.
Regional Market Size (USD Mn)
Market estimates by geography (2027)
InsightAmericas leads with $2.08B by 2027.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2016 | 2019 | 2027 | CAGR | SHARE |
|---|---|---|---|---|---|
| Europe | $148.17M | $354.95M | $779.82M | 16.3% | 23% |
| Asia Pacific | $82.84M | $196.91M | $429.80M | 16.1% | 13% |
| Middle East and Africa | $38.48M | $68.09M | $105.95M | 9.6% | 3% |
| Americas | $391.89M | $942.76M | $2.08B | 16.4% | 61% |
| Total | $661.38M | $1.56B | $3.39B | 16.0% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSegment Revenue (2027)
Reagents & Consumables
Services
Instruments
Analysis and Data Interpretation Solutions
0618123518532470
Segment Market Share
- Reagents & Consumables66%
- Services16%
- Instruments13%
- Analysis and Data Interpretation Solutions5%
Total Market Size
$3.39B
Market by Segment (2027)
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Reagents & Consumables | $2.25B | 16.0% | 40% |
| Services | $534.71M | 16.0% | 89% |
| Instruments | $452.82M | 16.0% | 89% |
| Analysis and Data Interpretation Solutions | $161.22M | 16.0% | 85% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Metagenomic Sequencing Market — Key Findings
Analytical insights on Metagenomic Sequencing Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Metagenomic Sequencing Market market is projected to reach $3.39B by 2027, growing at 16.0% CAGR. The Reagents & Consumables segment holds the largest share.
Market Dynamics
Metagenomic sequencing is a modern genomics technique that helps in the analysis of microbial DNA from various environmental communities. Metagenomics sequencing allows researchers to analyze genes in any given sample. This method enables the access of bacterial diversity and identifies the presence of microbes in various environments.
Factors that drive the market growth are the wide range of applications of metagenomics in various fields, rising government funding and initiatives for growth of sequencing techniques, and declining cost of sequencing. However, unfavorable regulatory policies are hampering the growth of the market.
Market Drivers
Genomics analyzes the fiction and structure of genomes. Genomics uses DNA sequencing to decode and analyze genomes. Gene sequencing is a useful tool for cancer diagnostic and various other infectious diseases. Recent medicine trends and collaborations of the healthcare industry with regulatory authorities for genome sequencing would support and expand genomic sequencing practices around the globe. Moreover, public and private funding for the development of genomic research is also likely to support market growth. This favorable scenario creates an opportunity for the metagenomic sequencing market.
Some of the major genome mapping and funding programs supporting the market growth include,
In 2016, the government of France announced a program, namely, the “Medecine Genomique 2025”. This program aims to open 12 genome sequencing centers in France.In 2017, XIFIN Inc. launched the next-generation sequencing module. This module delivers advanced workflow functionality for laboratory sequencing operations and precision medicine.National Human Genome Research Institute (NHGRI) in 2019, awarded USD 2.5 million to Washington University in St. Louis (WashU), University of California, Santa Cruz (UCSC), and the European Bioinformatics Institute (EBI), which will coordinate with the National Center for Biotechnology Information, to form the WashU-UCSC-EBI Human Genome Reference Center. This center aims to provide a next-generation reference sequence of the human genome as a resource for the scientific community and support interactions within the genomics community.In 2018, All of Us Research Program, a part of the National Institutes of Health, awarded funds over USD 28.6 million to establish three genome centers in the US. These centers will produce genome data for researchers and program’s precision medicine research platform, a national resource to support studies on a variety of important health questions.
Market Opportunities
Many companies face challenges in storing the sequencing test data. The genome sequencing technology produces a large volume of sequencing data during the research activity. Large data creates storage challenges for the operator. The cloud-based technology helps resolve the storage issue in sequencing data. Cloud-based solutions are used for data storage, effective data management, and analysis of the large volume of data. This advantage helps companies to focus on cloud-based technology. Cloud-based solutions create an opportunity for companies to develop and capture the maximum share in the metagenomic sequencing market. Recently in January 2018, Illumina launched BaseSpace Sequence in China. It is a cloud-based solution used for genomic data storage and analysis of samples.
This cloud-based technology acts as an opportunity for the growth of the metagenomic sequencing market
Market Restraints
Reimbursement policies for genome sequencing testing vary widely among private and public insurers. The availability of funding and reimbursement is only for the FDA approved NGS tests, which are performed in laboratories. The reimbursement is not applicable for genome sequencing tests, which are not approved by the FDA. Recently, the Centers for Medicare and Medicaid Services finalized the National Coverage Determination to cover only FDA approved diagnostic laboratory tests used for genome sequencing for patients who have advanced cancer.
This unfavorable reimbursement policy impacts on implementation and adoption of genome sequencing testing performed in laboratories. The testing cost is a major barrier to the implementation of genome sequencing testing. Due to the high cost of genome sequencing testing, it is still not affordable for patients. These unfavorable regulatory policies towards genome sequencing tests would restrain the metagenomic sequencing market during the forecast period.
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Market Value by Segment (2027)
Reagents & Consumables
Services
Instruments
Analysis and Data Interpretation Solutions
Companies
Key companies profiled in Metagenomic Sequencing Market
Profiles of 109 companies operating in the Metagenomic Sequencing Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
BGI
BGI
Healthcare
Company Headquarters: Shenzhen, China Founded: 1999 Workforce: ~3150 Company Working: BGI is a publicly listed commercial genomics company. It is one of the leading life science and genomics organizations. The company has world-leading bio-informatics research and development, large scale computing infrastructure for data output and storage, and proprietary sequencing platforms. It operates through molecular genetics, sequencing services, mass spec, and pharma solutions. It offers a wide range of integrated genomic and proteomic services and solutions for medical institutions, research institutions, and other public and private partners. BGI offers its genomics and proteomics services in research areas, such as cancer, metagenomics, drug discovery, reproductive health, and biomarker discovery. It has a presence in more than 100 countries and regions around the world and has a large network of service laboratories in China, Hong Kong, the US, and Europe.
Revenue$0.2B
Employees3,150
Market CapN/A
Founded1998
Shenzhen, China
Illumina I
Illumina Inc.
Healthcare
Company Headquarters: California, US Founded: 1998 Workforce: 7,700+ Company Working: Illumina, Inc. (Illumina) operates in genomics, an industry at the intersection of biology and technology. Illumina focuses on innovating and improving human health by offering a wide range of innovative products. Its initial products have enabled researchers to explore DNA at an entirely new scale and helped them create the first map of gene variations associated with health, disease, and drug response. It serves customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. It has a presence in major regions such as North America, Europe, and Asia.
Revenue$2.4B
Employees7,700
Market CapN/A
Founded1997
California, US
Qiagen
Qiagen
Healthcare
Company Headquarters: Germany, Europe Founded: 1984 Workforce: 5,000 Company Working: Qiagen is a healthcare company that deals in sample and assay technologies for molecular diagnostics. The company operates through more than 35 offices spread in over 25 countries. It serves more than 500,000 customers across the globe. Its product portfolio spans through a full range of molecular testing applications. Qiagen’s products are used for extraction, purification, and stabilization of DNA, RNA, and protein from various biological samples. It has over 500 core products in its portfolio. The company is listed on the New York Stock and Frankfurt Prime Standard exchanges. It offers its products in various areas such as discovery & translational research, diagnostics & clinical research, next-generation sequencing, and instruments & automation.
Revenue$1.3B
Employees5,000
Market CapN/A
Founded1983
Germany, Europe
Thermo Fis
Thermo Fisher Scientific
Healthcare
Company Headquarters: Massachusetts, US Founded: 2006 Workforce: ~70,000+ Company Working: Thermo Fisher Scientific specializes in various biotechnology products such as analytical instruments, laboratory supply chain programs and e-commerce, laboratory equipment, lab services, specialty diagnostics, and others. The company helps its customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to the market, and increase the productivity of the laboratory. It has five premier brands, namely, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services through which it offers an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.
Revenue$18.3B
Employees70,000
Market CapN/A
Founded2005
Massachusetts, US
Eurofins S
Eurofins Scientific
Healthcare
Company Headquarters: Luxembourg Founded: 1987 Workforce: 45,000 Company Working: Eurofins Scientific is a leader in analytical testing services that provides clinical tests and laboratory services in drug discovery pharmacology, genomics, forensics, contract manufacturing organization (CMO), advanced material sciences, and for supporting clinical studies across multiple industries. Pharmaceutical, environment, food, and cosmetics are the major clients for Eurofins Scientific’s products. The company has around 800 laboratories across 47 countries. It has a portfolio of over 200,000 analytical methods to evaluate and identify the safety, composition, authenticity, purity, and origin of biological substances and products, also used in clinical diagnostics. Geographically, the company operates in North America and South America, Europe, and Asia-Pacific.
Revenue$2.4B
Employees45,000
Market CapN/A
Founded1986
Luxembourg
PerkinElme
PerkinElmer Inc
Healthcare
Company Headquarters: US Founded: 1937 Workforce: ~13,000 Company Address: PerkinElmer Inc, 331 Treble Cove Rd, Billerica, Massachusetts, 01862 US. Contact Details: Product Sales: California (1-408-232-0653); Puerto Rico (1-787 783 3067); Connecticut (1-203-905-4600); Investor Relation Contact (ir@perkinelmer.com Tel: (781) 663 6900, Address: 940 Winter Street, Waltham, MA 02451 US) Company Working: PerkinElmer Inc (PerkinElmer) is largely engaged in providing solutions to diagnostics, delivery, and analytical solutions markets. The company deals in creating innovative solutions for better and fast diagnosis of various health issues worldwide. It pioneers in scientific technologies for better detection, imaging, and informatics. The company serves its customers in over 150 countries. PerkinElmer has nearly 3,500 patents active and operates in clinical research, life sciences, food, environmental, and industrial markets.
Revenue$2.1B
Employees13,000
Market CapN/A
Founded1936
US
Page 1 of 19
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Metagenomic Sequencing Market
Starting from
$4,950